Cargando…

Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab

Detalles Bibliográficos
Autores principales:	Jung, Chul Won, Cho, Su-Hee, Park, Sylvia, Jang, Jun Ho, Ji, Jun Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234246/ https://www.ncbi.nlm.nih.gov/pubmed/28090498 http://dx.doi.org/10.5045/br.2016.51.4.297

Ejemplares similares

New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients
por: Yoon, Jun Seok, et al.
Publicado: (2018)

Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
por: Palombi, Massimiliano, et al.
Publicado: (2016)

A case of immune thrombocytopenia associated with invasive thymoma successfully treated with eltrombopag
por: Yoon, Jung-Ki, et al.
Publicado: (2019)

A Case of Refractory Thrombocytopenia with 5q Deletion: Myelodysplastic Syndrome Mimicking Idiopathic Thrombocytopenic Purpura
por: Chang, Jeonghyun, et al.
Publicado: (2014)

Long-term efficacy of alemtuzumab in polymyositis
por: Ruck, Tobias, et al.
Publicado: (2015)

Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab
por: Strüßmann, Tim, et al.
Publicado: (2022)

Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination
por: Saito, Kei, et al.
Publicado: (2021)

Refractory Nonconvulsive Status Epilepticus with Favorable Outcome in a Patient with Marchiafava-Bignami Disease
por: Kim, Ryul, et al.
Publicado: (2019)

Encephalitis with Anti-SOX1 Antibodies Presenting with New-Onset Refractory Status Epilepticus
por: Cho, Hee-Jin, et al.
Publicado: (2019)

Mycobacterium haemophilum Infection after Alemtuzumab Treatment
por: Kamboj, Mini, et al.
Publicado: (2008)

Reply: Comment on alemtuzumab and inclusion body myositis
por: Dalakas, Marinos C., et al.
Publicado: (2010)

Therapy-related myeloid neoplasms after transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Yi, Jun Ho, et al.
Publicado: (2021)

Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease
por: Kim, Hyun Min, et al.
Publicado: (2023)

Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management
por: Cuker, Adam, et al.
Publicado: (2019)

Alemtuzumab in refractory Sézary syndrome
por: Reifs, Carmen María Alcántara, et al.
Publicado: (2016)

Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
por: Nam, Chang Hyun, et al.
Publicado: (2021)

Cerebral venous thrombosis in refractory idiopathic thrombocytopenia treated with eltrombopag
por: Nambiar, Vivek, et al.
Publicado: (2016)

Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis
por: Alamo, Angela, et al.
Publicado: (2019)

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Patients with Systemic Lupus Erythematosus
por: Atay, Didem, et al.
Publicado: (2012)

Vaccine-Induced Immune Thrombotic Thrombocytopenia: First Case Report in South Korea
por: Kim, Min Kyung, et al.
Publicado: (2021)

EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab
por: van de Langerijt, B., et al.
Publicado: (2010)

Successful treatment of steroid resistant hypereosinophilic syndrome with low-dose CsA
por: Jung, Yun Hwa, et al.
Publicado: (2013)

Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus
por: Lambert, Catherine, et al.
Publicado: (2018)

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
por: Metz, Imke, et al.
Publicado: (2016)

Pregnancy and immune thrombocytopenia: New trends
por: Yavaşoğlu, İrfan, et al.
Publicado: (2020)

Drug-induced immune-mediated thrombocytopenia
por: Singh, Harpreet, et al.
Publicado: (2020)

Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
por: Tao, Lili, et al.
Publicado: (2017)

The study of transcriptome sequencing in childhood immune thrombocytopenia
por: Sun, Congcong, et al.
Publicado: (2019)

Immune Thrombocytopenia Following COVID-19 Vaccination
por: Isaac, Sangeetha, et al.
Publicado: (2022)

Successful management of intracranial hemorrhage in a patient with COVID-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous thrombosis
por: Shen, Chia-Fang, et al.
Publicado: (2022)

A rare case of pediatric immune thrombocytopenia with secondary antiphospholipid syndrome in Korea
por: Mun, Eun Ji, et al.
Publicado: (2022)

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia
por: Erçalışkan, Abdülkadir, et al.
Publicado: (2022)

Refractory necrotizing scleritis successfully treated with adalimumab
por: Lawuyi, Lola E., et al.
Publicado: (2016)

LSAMP Rearrangement in Acute Myeloid Leukemia With a Jumping Translocation Involving 3q13.31
por: Yoon, Jung, et al.
Publicado: (2021)

Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Covid-19 and Children with Immune Thrombocytopenia: Emerging Issues
por: Lassandro, Giuseppe, et al.
Publicado: (2020)

Immune Thrombocytopenia: A Rare Complication of Rabies Vaccine
por: Bansal, Sachin, et al.
Publicado: (2021)

Relapse of immune thrombocytopenia after COVID‐19 vaccination
por: van Dijk, Wobke E. M., et al.
Publicado: (2021)

Frequently Relapsing Post-COVID-19 Immune Thrombocytopenia
por: Serrano, Claudia, et al.
Publicado: (2021)

Management of immune thrombocytopenia: Korean experts recommendation in 2017
por: Jang, Jun Ho, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gddsqj4cvhsu16kl3ibm4480s0